 |
| BICX Bounces Back on TV Coverage Add PSID Back to Your Watchlists Now |
|
 Hot Stock to Watch
|
Company: PositiveID Corporation (OTCQB: PSID)
|
End of Day:
Price: 0.053
Change (%): - 0.004 (7.02)
Volume: 1,282,808 |
 |
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats and analyze biological samples.
Company Information Sheet
|
 Yesterday's Top Performer
|
Company: Bioheart Inc. (OTCQB: BHRT)
|
End of Day:
Price: 0.032
Change (%): + 0.0037 (13.07)
Volume: 2,838,767 |
 |
Bioheart Announces Joint Venture in South Africa
More Than 51 Million People Will Have Access to Bioheart's Therapies
SUNRISE, FL-(Marketwired - Jun 24, 2014) - Bioheart, Inc. (OTCBB: BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announced today that it has entered into a joint venture with Dr. Walter Bell of South Africa.
Dr. Walter Bell has been providing Bioheart therapies to patients in South Africa suffering from degenerative diseases since the end of 2013. Under this new agreement, the facilities in South Africa will be expanded to provide cell culture expansion and cryopreservation to local patients. Bioheart can multiply and preserve an individual’s cells in sub-zero temperatures for future treatments as required.
Continue Reading
|
Company: BioCorRx Inc. (OTCQB: BICX)
|
End of Day:
Price: 0.12
Change (%): + 0.015 (14.29)
Volume: 79,142 |
 |
Medical Implant Helps Addicts Recover Without Withdrawals
Child star Jeremy Miller was an addict until he discovered a new implantable drug that promised to put an end to his alcohol addiction.
Miller, known for his role as Ben Seaver in the popular 1980s sitcom "Growing Pains," started drinking alcohol when he was 19 years old.
“It became an all day, everyday thing,” Miller said. “It was four or five drinks a day, but it kept on like that for 15 years.”
On the verge of losing his family, Miller knew he couldn’t live that way, so he turned to Start Fresh Recovery for help.
Watch Video
Start Fresh program has high success rate to end alcoholism
Alcoholism is one of the most devastating problems in America. Studies show 53% of adults in the United States report one or more of their close relatives has a drinking problem.And once through recovery most alcoholics return to their drinking habits, but not with Start Fresh.
Watch Video |
Other Small Cap News
|
Company: Encision Inc. (Pink Sheets: ECIA)
|
Encision Receives FDA 510(k) Approval on its AEM EndoShield™ Burn Protection System
BOULDER, Colo., June 27, 2014 /PRNewswire/ -- Encision Inc. (Pink Sheets: ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has received FDA 510(k) premarket notification approval for its AEM Endoshield™ Burn Protection System ("EndoShield").
"We are pleased to have achieved this milestone towards the introduction of our EndoShield burn protection system," said Greg Trudel, Encision's President & CEO. "EndoShield integrates our patented AEM® technology into a disposable smart cord and eliminates the need for a separate AEM monitor. Feedback from the marketplace has been very positive.
Continue Reading
|
Company: FutureWorld (OTCQB: FWDG)
|
FutureWorld (FWDG) Provides Shareholder Update II
Evolution to Cannabis 2.0
ST. PETERSBURG, FL, June 27, 2014 (GLOBE NEWSWIRE) -- FutureWorld (OTCQB: FWDG), a leading provider of advanced solutions to the Cannabis industry globally, announces the following letter to its shareholders from our Chairman & CEO Sam Talari:
Dear Fellow Shareholders, As the CEO of FutureWorld, I would like to update all of our shareholders on our current business and events:
We are currently involved in many "picks and shovel" ancillary business enterprises associated with the Hemp/Cannabis industry and will continue to delve even further as the space continues to evolve. Our overall strategy is to have a foot print in all states that have a legalized Cannabis marketplace (Hemp especially) with diverse products and services. This will allow us to be at the forefront of this growth industry which may at some point surpass even the tobacco market now worth close to $200 billion per year.
Continue Reading |
Market News
|
By Lee Brodie: CNBC
|
Cramer: Best bets for second half
With only a handful of days left in June, Jim Cramer is scouring the market, looking for new ideas for the second half.
And as he sifted through a pile of earnings and other data, Chevron grabbed his attention, largely because the stock just broke out of a trading range.
For the past year, Cramer says, Chevron had been stuck in a rut. "It was a stock that needed to be bought every time it dipped below $120 and then sold every time it got to the high $120s," he said.
Continue Reading
|
By Peter Schacknow: CNBC
|
Early movers: NKE, DD, PFE, GM, INTC, BMY & more
Check out which companies are making headlines before the bell:
Nike - Nike reported fourth quarter profit of 78 cents per share, three cents above estimates. Revenue also exceeded consensus, with Nike getting results from its marketing push ahead of the 2014 World Cup.
DuPont - DuPont cut its second quarter and full-year earnings guidance, pointing to slower than expected sales growth in its agriculture and performance chemicals units.
Finish Line - The athletic apparel company earned 28 cents per share for the first quarter, seven cents above estimates, with revenue also beating consensus. Finish Line credits its relationship with Macy's for helping it expand its market share.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
